Our lab focuses on translational bedside-to-bench research with the use of high throughput technologies such as genomics and proteomics, to unravel the complex heterogeneity of kidney diseases, solid organ transplant rejection and tolerance. The aim of these studies is to identify potentially important diagnostic, prognostic and therapeutic markers for disease monitoring, treatment and prognosis. We have applied our studies to improve outcomes in pediatric kidney transplantation by identification of markers for acute rejection risk stratification, chronic non-human primate vascular injury, and based on our work, also developed a complete steroid avoidance protocol in pediatric kidney transplantation (currently the basis of a multicenter randomized NIH funded study).
Lab News!
medpage TODAY- Chronic Transplant Rejection Response Varies within the Kidney
Cystinosis Foundation Ireland’s new newsletter
Transplant patients may soon go steroid-free